Research
Hormonal
Semaglutide treatment resolves prediabetes and normalizes HbA1c levels in post-bariatric patients, even in those who did not achieve full diabetes remission post-surgery.
If you had bariatric surgery and still have prediabetes, semaglutide can help normalize your blood sugar levels. In this study, all patients with prediabetes who took semaglutide for a year achieved normal glucose levels. This highlights the importance of ongoing metabolic management after surgery.
ModerateSupportsMEDIUM confidence
Among patients with prediabetes (n = 6), 12 months treatment led to normoglycemia in all patients (p < .05).
Why this rating
Small subgroup (n=6) within a retrospective study.
Source
Sustained weight loss with semaglutide once weekly in patients without type 2 diabetes and post‐bariatric treatment failure
Anne Lautenbach et al. · Clinical Obesity · 2023
DOI 10.1111/cob.12593
cohort · n=29Cited 31×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →